Our expertise is built upon a foundation of deep industry knowledge, scientific acumen, well-cultivated contacts, and a passion for getting the job done.
Whether we're working with a pre-clinical, biopharmaceutical company targeting a next-generation therapy for Alzheimer's disease or a NASDAQ-traded company pursuing a dual-track program to test and commercialize a blood-based diagnostic for appendicitis, TSAI understands the core dynamics that must be communicated and the audiences that must be engaged in order to unlock each company's full potential.
We communicate to investors to enhance a company's valuation. We communicate to industry strategics to advance partnering discussions. We communicate to the media to earn validation and broaden a company's appeal.